Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.


Search Results to Andrew Kraft

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Kraft, Andrew

Item TypeName
Concept Prostatic Neoplasms
Concept Prostatic Neoplasms, Castration-Resistant
Academic Article A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.
Academic Article Pim family kinases enhance tumor growth of prostate cancer cells.
Academic Article The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim.
Academic Article Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer.
Academic Article p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.
Academic Article PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species.
Academic Article Overexpression of the oncogenic kinase Pim-1 leads to genomic instability.
Academic Article Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737.
Academic Article Elevation of receptor tyrosine kinases by small molecule AKT inhibitors in prostate cancer is mediated by Pim-1.
Academic Article Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade.
Academic Article Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells.
Grant Pim 1 Protein Kinase in Regulating Stromal Cell Biology in Prostate Cancer
Grant Hollings Cancer Center Planning Grant
Grant Regulation of P-Body Formation and mRNA Decapping in Cancer: Control by AKT and Pim Kinase Phosphorylation of EDC3
Grant Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
Grant Novel Inhibitors of Pim Protein Kinases

Search Criteria
  • Prostatic Neoplasms

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)